Aardvark Therapeutics, Inc. Common Stock (AARD) vs Apyx Medical Corporation (APYX)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Apyx Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
APYX
Apyx Medical Corporation
$2.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AARD vs APYX
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)APYX +85.7% (+36.3%/yr)APYX compounded faster over this window
Log scale — wide-divergence pair
AARD APYX
AARD vs APYX: by the numbers
- •AARD is the larger company ($114M vs $109M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -14.78% net margin).
Metrics side by side
Valuation
| Metric | AARD | APYX |
|---|---|---|
| P/S ratio | N/A | 1.87 |
| P/B ratio | 1.53 | 10.27 |
Profitability
| Metric | AARD | APYX |
|---|---|---|
| Gross margin | 0.00% | 33.94% |
| Operating margin | 0.00% | -6.06% |
| Net margin | 0.00% | -14.78% |
| ROE | -93.44% | -80.97% |
| ROIC | -97.99% | -6.84% |
Growth (annualized)
| Metric | AARD | APYX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.82% |
| Total return CAGR (5Y) | N/A | -28.10% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROEApyx Medical ROEAardvark Therapeutics, Inc. Common Stock operating marginApyx Medical operating marginAardvark Therapeutics, Inc. Common Stock revenue growthApyx Medical revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowApyx Medical free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.